The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net loss | -77,001 |
| Share-based compensation | 5,771 |
| Stock issued for services | 200 |
| Depreciation | 9,579 |
| Bad debt expense | 385 |
| Intangibles and other amortization expense | 46 |
| Debt related fees and amortization expense | 6,707 |
| Accretion and other expenses of series a preferred units | 8,226 |
| Gain (loss) on asset disposals | 4 |
| Gain on debt/liability extinguishment | 1,007 |
| Loss on impairment of intangibles | 43 |
| Accounts receivable | -1,302 |
| Inventories | -13,115 |
| Prepaid expenses | -276 |
| Tax credit sale receivable | -12,300 |
| Other assets | 4,537 |
| Accounts payable | -7,533 |
| Accrued interest expense and fees, net of interest paid | 30,790 |
| Other liabilities | 4,605 |
| Net cash provided by (used in) operating activities | 3,263 |
| Capital expenditures | 26,002 |
| Grant proceeds received for capital expenditures | 411 |
| Net cash used in investing activities | -25,591 |
| Proceeds from borrowings | 44,926 |
| Repayments of borrowings | 37,104 |
| Lender debt renewal and waiver fee payments | 1,307 |
| Payments on series a preferred financing | 8,270 |
| Payments on finance leases | 168 |
| Proceeds from sales of common stock | 28,075 |
| Proceeds from the exercise of stock options | 257 |
| Net cash provided by financing activities | 26,409 |
| Effect of exchange rate changes on cash and cash equivalents and restricted cash | -26 |
| Net change in cash and cash equivalents and restricted cash for period | 4,055 |
| Cash, cash equivalents, and restricted cash at beginning of period | 3,831 |
| Cash, cash equivalents, and restricted cash at end of period | 7,886 |
AEMETIS, INC (AMTX)
AEMETIS, INC (AMTX)